The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Kaifang,Ma

第一单位： Department of Urology, Peking University First Hospital, Beijing, China.

作者： Kaifang,Ma ^[1] ; Baoan,Hong ^[2] ; Jingcheng,Zhou ^[3] ; Yanqing,Gong ^[4] ; Jiangyi,Wang ^[5] ; Shengjie,Liu ^[6] ; Xiang,Peng ^[1] ; Bowen,Zhou ^[2] ; Jiufeng,Zhang ^[3] ; Haibiao,Xie ^[4] ; Kenan,Zhang ^[1] ; Lei,Li ^[2] ; Desheng,Cai ^[3] ; Zixin,Wang ^[4] ; Lin,Cai ^[7] ; Kan,Gong ^[8]

作者单位： Department of Urology, Peking University First Hospital, Beijing, China. ^[1] Hereditary Kidney Cancer Research Center, Peking University First Hospital, Beijing, China. ^[2] Institute of Urology, Peking University, Beijing, China. ^[3] National Urological Cancer Center, Beijing, China. ^[4] Department of Urology, Beijing Cancer Hospital, Beijing, China. ^[5] Beijing Institute for Cancer Research, Beijing, China. ^[6] Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China. ^[7] Department of Urology, National Center of Gerontology, Beijing Hospital, Beijing, China. ^[8] Department of Urology, The Second Affiliated Hospital of Nanchang University, Nanchang, China. ^[9]

关键词 axitinib efficacy renal cell carcinoma safety sorafenib sunitinib tyrosine kinase inhibitors von Hippel-Lindau disease

DOI 10.3389/fonc.2019.01122

PMID 31737565

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2019年9卷

1122页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The Efficacy and Safety of Tyrosine Kinase Inhibitors for Von Hippel-Lindau Disease: A Retrospective Study of 32 Patients.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除